Literature DB >> 21948455

Discrimination between silicone oil droplets and protein aggregates in biopharmaceuticals: a novel multiparametric image filter for sub-visible particles in microflow imaging analysis.

René Strehl1, Verena Rombach-Riegraf, Manuel Diez, Kamal Egodage, Markus Bluemel, Margit Jeschke, Atanas V Koulov.   

Abstract

PURPOSE: Accurate monitoring of the sub-visible particle load in protein biopharmaceuticals is increasingly important to drug development. Manufacturers are expected to characterize and control sub-visible protein particles in their products due to their potential immunogenicity. Light obscuration, the most commonly used analytical tool to count microscopic particles, does not allow discrimination between potentially harmful protein aggregates and harmless pharmaceutical components, e.g. silicone oil, commonly present in drug products. Microscopic image analysis in flow-microscopy techniques allows not only counting, but also classification of sub-visible particles based on morphology. We present a novel approach to define software filters for analysis of particle morphology in flow-microscopic images enhancing the capabilities of flow-microscopy.
METHODS: Image morphology analysis was applied to analyze flow-microscopy data from experimental test sets of protein aggregates and silicone oil suspensions.
RESULTS: A combination of four image morphology parameters was found to provide a reliable basis for automatic distinction between silicone oil droplets and protein aggregates in protein biopharmaceuticals resulting in low misclassification errors.
CONCLUSIONS: A novel, custom-made software filter for discrimination between proteinaceous particles and silicone oil droplets in flow-microscopy imaging analysis was successfully developed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21948455     DOI: 10.1007/s11095-011-0590-7

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  8 in total

Review 1.  Effects of protein aggregates: an immunologic perspective.

Authors:  Amy S Rosenberg
Journal:  AAPS J       Date:  2006-08-04       Impact factor: 4.009

2.  Quantitation of protein particles in parenteral solutions using micro-flow imaging.

Authors:  Chi-Ting Huang; Deepak Sharma; Peter Oma; Rajesh Krishnamurthy
Journal:  J Pharm Sci       Date:  2009-09       Impact factor: 3.534

Review 3.  An industry perspective on the monitoring of subvisible particles as a quality attribute for protein therapeutics.

Authors:  Satish K Singh; Nataliya Afonina; Michel Awwad; Karoline Bechtold-Peters; Jeffrey T Blue; Danny Chou; Mary Cromwell; Hans-Juergen Krause; Hanns-Christian Mahler; Brian K Meyer; Linda Narhi; Doug P Nesta; Thomas Spitznagel
Journal:  J Pharm Sci       Date:  2010-08       Impact factor: 3.534

Review 4.  Protein aggregation: pathways, induction factors and analysis.

Authors:  Hanns-Christian Mahler; Wolfgang Friess; Ulla Grauschopf; Sylvia Kiese
Journal:  J Pharm Sci       Date:  2009-09       Impact factor: 3.534

5.  Development of a microflow digital imaging assay to characterize protein particulates during storage of a high concentration IgG1 monoclonal antibody formulation.

Authors:  Klaus Wuchner; Jochen Büchler; Rene Spycher; Paul Dalmonte; David B Volkin
Journal:  J Pharm Sci       Date:  2010-08       Impact factor: 3.534

6.  Silicone oil microdroplets and protein aggregates in repackaged bevacizumab and ranibizumab: effects of long-term storage and product mishandling.

Authors:  Lu Liu; David A Ammar; Lindsey A Ross; Naresh Mandava; Malik Y Kahook; John F Carpenter
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-22       Impact factor: 4.799

7.  Micro-flow imaging: flow microscopy applied to sub-visible particulate analysis in protein formulations.

Authors:  Deepak K Sharma; Dave King; Peter Oma; Clark Merchant
Journal:  AAPS J       Date:  2010-06-02       Impact factor: 4.009

8.  Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality.

Authors:  John F Carpenter; Theodore W Randolph; Wim Jiskoot; Daan J A Crommelin; C Russell Middaugh; Gerhard Winter; Ying-Xin Fan; Susan Kirshner; Daniela Verthelyi; Steven Kozlowski; Kathleen A Clouse; Patrick G Swann; Amy Rosenberg; Barry Cherney
Journal:  J Pharm Sci       Date:  2009-04       Impact factor: 3.534

  8 in total
  13 in total

1.  Flow imaging microscopy for protein particle analysis--a comparative evaluation of four different analytical instruments.

Authors:  Sarah Zölls; Daniel Weinbuch; Michael Wiggenhorn; Gerhard Winter; Wolfgang Friess; Wim Jiskoot; Andrea Hawe
Journal:  AAPS J       Date:  2013-08-31       Impact factor: 4.009

Review 2.  Protein particulate detection issues in biotherapeutics development--current status.

Authors:  Tapan K Das
Journal:  AAPS PharmSciTech       Date:  2012-05-08       Impact factor: 3.246

3.  Quality of bevacizumab compounded for intravitreal administration.

Authors:  J M Palmer; W M Amoaku; F Kamali
Journal:  Eye (Lond)       Date:  2013-06-21       Impact factor: 3.775

4.  Flow Microscopy Imaging Is Sensitive to Characteristics of Subvisible Particles in Peginesatide Formulations Associated With Severe Adverse Reactions.

Authors:  Austin L Daniels; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2018-02-01       Impact factor: 3.534

5.  Radar chart array analysis to visualize effects of formulation variables on IgG1 particle formation as measured by multiple analytical techniques.

Authors:  Cavan Kalonia; Ozan S Kumru; Jae Hyun Kim; C Russell Middaugh; David B Volkin
Journal:  J Pharm Sci       Date:  2013-10-09       Impact factor: 3.534

6.  Cell confluency analysis on microcarriers by micro-flow imaging.

Authors:  Christopher J Farrell; Stephanie M Cicalese; Harrison B Davis; Belma Dogdas; Tosha Shah; Tim Culp; Van M Hoang
Journal:  Cytotechnology       Date:  2016-05-14       Impact factor: 2.058

7.  Protein-protein interactions controlling interfacial aggregation of rhIL-1ra are not described by simple colloid models.

Authors:  Lea L Sorret; Madison A DeWinter; Daniel K Schwartz; Theodore W Randolph
Journal:  Protein Sci       Date:  2018-03-03       Impact factor: 6.725

8.  Holographic Characterization of Protein Aggregates in the Presence of Silicone Oil and Surfactants.

Authors:  Priya N O Kasimbeg; Fook Chiong Cheong; David B Ruffner; Jaroslaw M Blusewicz; Laura A Philips
Journal:  J Pharm Sci       Date:  2018-10-10       Impact factor: 3.534

9.  Oil-Immersion Flow Imaging Microscopy for Quantification and Morphological Characterization of Submicron Particles in Biopharmaceuticals.

Authors:  Nils Krause; Sebastian Kuhn; Erik Frotscher; Felix Nikels; Andrea Hawe; Patrick Garidel; Tim Menzen
Journal:  AAPS J       Date:  2021-01-04       Impact factor: 4.009

10.  A Random Forest Approach for Counting Silicone Oil Droplets and Protein Particles in Antibody Formulations Using Flow Microscopy.

Authors:  Miguel Saggu; Ankit R Patel; Theodoro Koulis
Journal:  Pharm Res       Date:  2016-12-19       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.